1. Home
  2. EXAS vs MOS Comparison

EXAS vs MOS Comparison

Compare EXAS & MOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • MOS
  • Stock Information
  • Founded
  • EXAS 1995
  • MOS 1987
  • Country
  • EXAS United States
  • MOS United States
  • Employees
  • EXAS N/A
  • MOS N/A
  • Industry
  • EXAS Medical Specialities
  • MOS Agricultural Chemicals
  • Sector
  • EXAS Health Care
  • MOS Industrials
  • Exchange
  • EXAS Nasdaq
  • MOS Nasdaq
  • Market Cap
  • EXAS 10.7B
  • MOS 11.2B
  • IPO Year
  • EXAS N/A
  • MOS 2004
  • Fundamental
  • Price
  • EXAS $52.48
  • MOS $37.69
  • Analyst Decision
  • EXAS Strong Buy
  • MOS Buy
  • Analyst Count
  • EXAS 20
  • MOS 12
  • Target Price
  • EXAS $70.16
  • MOS $35.33
  • AVG Volume (30 Days)
  • EXAS 2.7M
  • MOS 6.1M
  • Earning Date
  • EXAS 07-30-2025
  • MOS 08-05-2025
  • Dividend Yield
  • EXAS N/A
  • MOS 2.33%
  • EPS Growth
  • EXAS N/A
  • MOS N/A
  • EPS
  • EXAS N/A
  • MOS 1.15
  • Revenue
  • EXAS $2,828,128,000.00
  • MOS $11,064,300,000.00
  • Revenue This Year
  • EXAS $14.58
  • MOS $17.03
  • Revenue Next Year
  • EXAS $12.75
  • MOS N/A
  • P/E Ratio
  • EXAS N/A
  • MOS $32.63
  • Revenue Growth
  • EXAS 11.57
  • MOS N/A
  • 52 Week Low
  • EXAS $39.97
  • MOS $22.36
  • 52 Week High
  • EXAS $72.83
  • MOS $38.06
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 45.78
  • MOS 66.62
  • Support Level
  • EXAS $52.60
  • MOS $34.88
  • Resistance Level
  • EXAS $55.09
  • MOS $38.06
  • Average True Range (ATR)
  • EXAS 2.11
  • MOS 0.86
  • MACD
  • EXAS -0.06
  • MOS 0.07
  • Stochastic Oscillator
  • EXAS 32.69
  • MOS 88.21

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

Share on Social Networks: